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In the preceding paper of this  series  (1)  it was reported  that  the 
amount  of  specific  antibody  precipitable  by  the  capsular  polysac- 
charide is related to the mouse protective value of Type I antipneumo- 
coccus serum only under certain well defined conditions.  Thus with 
Type I  antipneumococcus  rabbit  serum  there  was  a  direct  propor- 
tionality between the two determined  values.  The  protective  ratio 
for immune rabbit serum, that is, the number of protective units per 
rag.  of specifically precipitable  nitrogen,  was,  however,  higher  than 
that  for Type I  antipneumococcus  horse  serum.  Moreover,  it was 
found that with the latter there existed at least two different protec- 
tive ratios.  Thus antipneumococcus rabbit sera average 1170 mouse 
protective units per rag.  of specifically precipitable nitrogen,  whereas 
horse sera fall into two groups having average values of 540 and 800 
units per rag.,  respectively. 
Several hypotheses  were advanced as  possible  explanations  for  the  differ- 
ences in the protective  ratios of  different lots of antipneumococcus horse sera. 
It was reasoned that  if,  according  to the  generally accepted thesis, the horse 
had formed only  one  antibody  specific for the  pneumococcus  capsular  poly- 
saccbarid~, the protective ratios  of  the  sera  might  differ because  of  certain 
secondary factors.  It is known, for example, that the protective  action of anti- 
pneumococcus horse  serum can  be readily  modified by admixture  with certain 
lipids in very small amounts  (2).  The  consistency of  the  results  within  the 
groups would necessitate  a degree of uniformity  in  distribution  of  secondary 
substances which would seem to render this possibility somewhat unlikely. 
It was also suggested as a possibility that more than one substance 
in  the  immune  horse  serum  might  possess the  capacity of reacting 
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with the capsular polysaccharide but that each of these possible anti- 
bodies might  possess characteristically  different  capacities  to  confer 
passive  protection  on  mice.  It  was  held  that  if  this  were  correct 
immune  horse  sera  might  represent  equilibrated  mixtures  of  anti- 
bodies, dominantly type specific, but varying in degree as to protective 
action.  These  various hypotheses are  somewhat difficult of experi- 
mental proof but two forms of experimentation have been devised to 
determine if all type specific antibodies in a  given antipneumococcus 
serum possess the same capacity to confer protection upon mice.  The 
first approach is based on the fractional precipitation of the antibody 
from serum  by the  addition of various amounts  of specific polysac- 
charide.  From  analyses  of  the  amount  of protein  specifically pre- 
cipitated and of the amount of protective antibody remaining in the 
absorbed serum, it is possible to calculate the protective value of each 
fraction  of  antibody  precipitated.  The  data  derived  from  experi- 
ments of this order form the subject matter of the present paper. 
A second and more direct approach has also been employed, namely, 
the attempt to isolate antibody proteins in more or less pure form with 
analyses of the protective values of the variously isolated fractions. 
The results of this study will be presented in a subsequent paper. 
EXPERIMENTAL 
Materials and Methods.--A detailed  description  of the immune sera, of the 
capsular  polysaccharide preparation,  and of the general methods  of procedure 
used in the present study has been given in the preceding paper (1).  In brief, the 
method for the determination  of the amount of specifically  precipitable nitrogen 
in the immune precipitates  is that proposed by Heidelberger  and Kendall  (3). 
Precipitates  are prepared in the col  d  and after 18 hours  at  4°C. are carefully 
washed twice with ice-cold saline.  Protein precipitated  is determined as nitro- 
gen.  For mouse protection  tests the method of Kirkbride,  Hendry, and Mur- 
dick (4) has been used and the results analyzed by the method of Muench (5). 
Experimental  evidence  supporting  the  accuracy  of  the  technical  procedures 
employed has been given in the preceding paper  (1). 
Immunological Fractionation of Antipneumococcus Horse Serum 
Heidelberger and Kendall in a  series of papers have demonstrated 
the  quantitative  interrelationships  between the  amount  of capsular 
polysaccharide added to a  specific immune  serum and  the  resultant 
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and predictable quantity of the specific antibody by the addition of a 
known amount of polysaccharide, and to estimate the amount of anti- 
body remaining in  solution either by  difference or by direct  deter- 
mination.  At the same time it is possible to estimate the amount of 
protective  antibody  remaining in  the  absorbed  serum  by  the  tests 
and  analytical  procedures  previously described  (1).  If  a  series  of 
partial absorptions is carried out and the supernatant fluids so remain- 
ing after each precipitation are analyzed, it is possible to calculate by 
difference the protective  potency of the  antibody removed by each 
addition of specific polysaccharide. 
In  the  first  experiment  Type  I  antipneumococcus  horse  serum, 
lot AA was used.  By repeated mouse protection titration against a 
standard  serum  the  test  serum  has been  found to  contain  approxi- 
mately 1405  protective units per cc. 
To each of a large series of tubes was added exactly 2.0 cc. of a 1:2 dilution 
of sediment-free  serum and the tubes were  then chilled.  Various  amounts of 
chilled capsular polysaccharide  solution were then added as indicated in Table I. 
The volumes were then made up precisely  to 4.0 cc.  with cold saline.  After 
18 hours at 4°C. all tubes were centrifuged for 1 hour in the cold.  The super- 
natant fluids were then decanted and those from duplicate tubes were pooled. 
The precipitates were carefully washed twice with ice-cold saline  and the pre- 
cipitated protein determined as nitrogen.  The analyses,  carried out in quad- 
ruplicate, therefore represent  the amount of nitrogen specifically precipitable 
from 1 cc. of serum by the indicated amount of polysaccharide. 
Simultaneous mouse protection tests were next carried  out with the super- 
natant solutions which represented exactly a 1-4 dilution of the original serum. 
The number of mouse protective units in the supernatant fluids was calculated 
by reference  to the unitage potency of the unadsorbed serum  as  previously 
determined by simultaneous titrations against a standard. 
Table I  shows the amounts of nitrogen specifically precipitated by 
the various amounts of capsular polysaccharide both as mg. per cc. 
of antiserum and in per cent with reference to the maximum amount 
of  specifically  precipitable  nitrogen.  From  these  data  have  been 
calculated the amounts of specific antibody nitrogen which in theory 
should still be present in the supernatant fluids.  That all precipitates 
(except VII) were formed on the antibody excess side of the equiva- 
lence zone was shown by the fact that none of the other supernatant 428  ANTIPNE~OCOCCUS  SERA.  II 
fluids  contained  immunologically  demonstrable  capsular  polysac- 
charide. 
The results of the mouse protection tests on the supernatant solu- 
tions in terms of dilution end-points (Muench 50 per cent system) are 
also  shown.  From  these  figures by  proportional calculation  have 
been derived the number of mouse protective units remaining in the 
supernatant  solutions.  The last  column gives the number of pro- 
tective units per mg. of specifically precipitable nitrogen. 
TABLE  I 
Fractional Precipitation of Antipneumococcus Horse Serum with Specific Capsular 
Polysacckaride  and the Determination  of tke Protective Potency of tke Unpre- 
cipitated Antibody in tke Supernatant  Fluid 
Supernatant fluids  N2 specifically  precipitated  Supcrnatant fluids 
Specific N2  (by difference)  Mouse protection  Obtained 
after addition 
Desig-  of capsular 
nation  polysaccha- 
ride rag. per 
I 
II 
III 
IV 
V 
VI 
VII 
cc. of serum 
i 
i  0 
0.025 
0.05 
0.06 
0.08 
0.10 
0,25 
Per cent  of 
Mg.  maximum 
specifically 
per cc.  prccipltable 
nitrogen 
0  0 
0.559  30.3 
0.923  50.1 
1.124  61.0 
1,342  72.8 
1.571  85.3 
1. 844  100,0 
Mg. 
per cc. 
1.844 
1,285 
0.921 
0.720 
0. 502 
0,273 
0 
Per cent of 
maximum 
specifically 
precipitable 
nitrogen 
100.0 
69,7 
49,9 
39.0 
27.2 
14.7 
0 
Calculated 
Dilution  units per cc, 
referred to  end-point  original 
serum 
1-109.4  1405 
1-87.7  1125 
1-64.0  822 
1-39,7  510 
1-13,6  175 
1-4,0  51 
--  0 
Protective 
units per mg. 
of specific N2 
(protective 
ratio) 
760 
876 
893 
7O8 
349 
187 
From these  results  it  will  first be  noted that  the  admixture of 
0.25  rag.  capsular polysaccharide with  1.0 cc.  of serum removed all 
of the protective antibody.  Each addition of polysaccharlde removed 
a certain amount of protective antibody, but the relationship between 
protective potency and specifically precipitable protein remaining in 
solution is not linear.  Thus it will be noted that with the removal 
of the first 30 per cent of specifically precipitable nitrogen the antibody 
remaining in solution showed a  higher protective ratio than that in 
the original unabsorbed serum.  The direction of this change, how- 
ever, was reversed following the removal of 60 per cent of the  pre- KENNETH  GOODNER  AND  ?RANK  L.  HORSFALL,  JR.  429 
cipitable antibody, and as more and more antibody was removed the 
protective ratio of that  remaining in solution became progressively 
lower, until finally when 84 per cent had been precipitated the anti- 
body  remaining possesses  a  potency  of  only  187  protective  units 
per mg. 
It is obvious that all supernatant fluids previous to VI contained 
antibody of low protective potency.  It is possible, however, to arrive 
at the actual protective potency of each fraction of precipitable anti- 
body by a process of subtraction.  The results of these calculations 
are shown in Table II and presented diagrammatically in Text-fig. 1. 
TABLE  II 
Analyses of Protective Potencies of Various Fractions of the Specifically Precipi- 
table Antibody of Type I  Antipneumococcus Horse Serum 
Designation 
Fraction 
Reference 
supernatant 
designation 
I-II 
II-III 
III-IV 
IV-V 
V-VI 
VI-VII 
Position in pre- 
cipitable  range 
0  -30.3 
30.3-50.1 
50.1-61.0 
61.0-72.8 
72.8-85.3 
85.3-100.0 
Specific nitrogen 
content of frac- 
tion (by differ- 
ence from 
Table I) 
0. 559 
0.364 
0. 201 
0.218 
0.229 
0. 273 
Protective units 
in fraction (by 
difference from 
Table I) 
280 
303 
312 
335 
124 
51 
Protective 
ratios:  Units 
per rag. specific 
N2 
505 
830 
1550 
1540 
540 
187 
It will be noted that the antibody precipitated by the addition of 
the smallest amount of capsular polysaccharide possessed a protective 
ratio (505 units per rag.) much lower than that of the antibody in the 
unabsorbed serum  (760 units per rag.).  Similarly the last  fraction 
precipitated (No. 6)  possessed an extremely low protective potency 
(187 units per rag.).  Between these two low protective ratios, how- 
ever, there exists a range in which the mouse protective value is very 
high,  approximately  1550 units per rag.  of  specifically precipitable 
nitrogen which is almost exactly twice the figure for the unabsorbed 
serum. 
Repeated experiments as well as estimations of the probable errors 430  ANTIPNEUMOCOCCUS  SERA.  II 
in the work lead  to the  conclusion that  although the actual  figures 
may not be absolute the comparative values are correct. 
It  is  quite  apparent  from  these  results  that  those  substances  in 
antipneumococcus horse serum which are considered as specific anti- 
bodies  do  not possess  equal  properties  as  regards  their  capacity  to 
protect mice against infection. 
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TT.xT-FxG. 1.  Protective  potencies  of  various  fractions  of  the  specifically 
precipitable antibody of Type I antipneumococcus horse serum. 
These results might be interpreted  as demonstrating the existence 
in an immune horse serum of a  large series of antibodies of varying 
potencies.  A  simpler conception would be that in antipneumococcus 
horse serum there exist at least three substances possessing all of the 
properties  of  specific  antibodies.  That  which  is  first  precipitated 
upon the addition of polysaccharide might be thought of as possessing 
a  great  avidity 1 but for some reason  a  low protective  value.  That 
l The term avidity is here used in the more commonly accepted sense of rate 
of visible reaction rather than with reference to antigeu-antibody union proper. KENNETH  GOODNER  AND  FRANK  L.  HORSFALL,  JR.  431 
which occupies the intermediate position has less avidity but a very 
high mouse protective valuel  That which is last precipitated has the 
lowest  avidity  and  also  the  lowest  protective  value.  The  figures 
obtained  in this  analysis  undoubtedly  do  not  represent the  actual 
values inasmuch as these fractions probably still represent mixtures. 
Immunological Fractionation of Antipneumococcus Rabbit Serum 
A similar procedure of immunological fractionation has been carried 
out with Type I  antipneumococcus rabbit serum and the results are 
presented in Table III. 
TABLE  III 
Fractional Precipitation  of A ntipneumococcus Rabbit Serum with Specific Capsular 
Polysacckaride and tke  Determination of tke  Protective Potency of tke  Unpre- 
cipitated Antibody in tke Supernatant Fluid 
Supernatant fluids  N~ specifically  pre-  cipitatecl  Supernatant fluids 
Obtained 
after addi- 
Deslg-  tion of  capsular 
nation  polysacchar- 
ide mg. per 
cc. of serum 
I  0 
II  0.045 
III  0.110 
IV  0.150 
V  0.350 
Per cent of 
maximum 
Mg.  specifically 
per cc,  precipitable 
nitrogen 
0  0 
0.398  26.0 
0. 936  61.5 
1.196  78.1 
1.533  100.0 
Specific N2 
(by difference) 
Mg. 
per  cc. 
1.533 
1.135 
0.597 
0.337 
0 
Per cent of 
innJ~tinum 
specifically 
precipltable 
nitrogen 
100.0 
74.0 
38.5 
21.9 
0 
Mouse protection 
Calculated 
Dilution  units  per 
end-point cc.  referred 
to  original 
serura 
1-106.8  1830 
1-78.7  1348 
1-45.1  773 
1-28.3  485 
1-10-8  185 
Protective 
units per rag. 
of specific 
N2 (protec- 
tive  ratio  ) 
1195 
1190 
1295 
1440 
The application of this method to immune rabbit serum is rendered 
somewhat difficult by the fact that  the protective antibody is not 
completely precipitated by the capsular polysaccharide as now pre- 
pared.  For  this  reason  the  apparent  number  of  protective  units 
per rag. of precipitable nitrogen in the supernatant of precipitate VI 
is infinitely high.  This same factor tends to distort  somewhat the 
values in all preceding supernatants.  By the determination of agglu- 
tinin nitrogen by the method of Heidelberger and Kabat (7)  it has 
been found that at least 6 per cent of the specific antibody is not 
precipitated by the polysaccharide preparation used.  This amount 432  ANTmNEU~OCOCCUS  SERA.  n 
corresponds quite well with the amount of protective substances 
remaining in the supernatant  solution. 
TABLE  IV 
Analyses of Protective Potencies of Various Fractions  of tke Specifically  Precipi- 
table Antibody of Type I Anti ~neumococcus Rabbit Serum 
Fraction 
Reference 
Designation  supernatant 
designation 
I  I-II 
2  II-III 
3  III-IV 
4  IV-V 
Position 
in precipitable 
range 
~¢r cent 
0  -26.0 
26.0-61.5 
61.5-78.1 
78.1-100.0 
Specific nitrogen 
content of 
fraction (by 
difference  from 
Table  III) 
0.398 
0.538 
0.260 
0337 
Protective 
units in 
fraction (by 
difference from 
Table III) 
482 
575 
288 
300 
Protective 
ratios:  Units 
per rag. 
specific  N2 
1210 
1170 
1105 
890 
1000 
f~ 
500 
"6-"  0  20  40  60  80  t00 
l:k~canla~e range of pfecipitabiii~ 
TExT-FIo.  2.  Protective  potencies of  various fractions of  the  specifically 
precipitable antibody of Type I antipneumococcus rabbit serum. 
This apparent defect is, however, eliminated by translation of the 
data, as in the case of horse serum, into terms of protective ratios for KENNETH  GOODNER  AND FRANK  L. HORSFALL, JR.  433 
each fraction.  These calculations  are  shown in Table  IV and pre- 
sented graphically in Text-fig. 2. 
From these data it will be noted that contrary to the observations 
with horse serum the antibody first precipitated from rabbit serum has 
a  high protective ratio.  In fact this protective value remains high 
throughout almost the  entire  range.  There  is  a  slight diminution 
with that antibody which is last precipitated. 
The simplest conception which served to describe the results with 
antipneumococcus rabbit serum is that  there  are  at  most only two 
substances which have all of the properties of specific antibodies and 
that both possess a  relatively high protective ratio.  In comparison 
with antipneumococcus horse serum the differences are slight.  These 
experiments furnish additional evidence as to the marked contrasting 
properties of the immune sera from the two animal species. 
The calculations  presented have been based on determinations as  to  the 
amount of antibody precipitated, that remaining after precipitation being es- 
timated by difference.  In each instance, however, the amount of precipitable 
antibody in the supernatant fluids was actually determined.  Since the deter- 
mined residual antibody showed a  quantitative parallelism  with the amount 
estimated by difference, the calculated protective ratios are so closely parallel 
to those reported that they need not be detailed. 
DISCUSSION  AND  SUMMARY 
The generally held view has been that in any immune serum only 
a single antibody would be induced by and react with a single antigen. 
Were this true the various manifestations of antibody activity should 
show  a  quantitative  parallelism.  It  has  already  been  shown  (1), 
however, that with antipneumococcus horse serum the mouse protec- 
tive potency does not parallel the maximum amount of specifically 
precipitable protein except within certain well defined groups of anti- 
sera,  The simplest explanation of this situation is that different horses 
form antibodies differing in specific protective capacity, but from our 
studies it seems probable that in any immune serum there may occur 
a mixture of antibodies which, while directed against the same antigen, 
possess  different  protective  capacities,  different  avidities,  etc.  It 
would now appear that this latter hypothesis is the more tenable since 
the experiments here reported indicate the existence of antibodies of 434  ANTIPNEIrMOCOCCUS  SERA.  II 
various protective potencies in horse antisera.  It would not be un- 
reasonable to hold that the antibodies of a  single serum represent a 
series  of substances with varying properties.  On  the  basis  of the 
present immunological  fractionation experiments, the following deduc- 
tions seem permissible. 
1.  Antipneumococcus horse sera must contain at least three, pos- 
sibly many, antibody substances which react with the capsular poly- 
saccharide.  These are:  (a)  A substance which precipitates upon the 
addition of a  relatively small amount of polysaccharide.  This anti- 
body possesses a  low protective potency.  (b)  A  substance which is 
precipitated with intermediate amounts of polysaccharide and which 
possesses an extremely high protective value.  (c)  A third substance 
which is precipitated only with the addition of relatively large amounts 
of polysaccharide.  The protective value of this antibody is very low 
It may represent a degraded form. 
2.  With antipneumococcus rabbit serum the situation is somewhat 
simpler.  This is in accord with the fact that with Type I  antipneu- 
mococcus sera  from  this  species  there  is  a  direct  proportionality 
between the amount of specifically precipitable protein and the pro- 
tective potency of the serum (1).  The results with antipneumococcus 
rabbit serum indicate the existence of at least two antibody substances: 
(a)  An  antibody  with  high protective  value  which makes  up  the 
greater  proportion  of  the  total  content.  (b)  A  second  substance 
which is precipitated only upon the addition of relatively large amounts 
of capsular polysaccharide.  The existence of this second antibody 
is not clearly demonstrated by the present findings but the lower pro- 
tective ratios obtained as greater amounts of antibody are removed 
probably indicate its  existence.  This may also represent degraded 
material. 
The observations on the antibodies of both horse and rabbit antisera 
will be supported by experiments with immunochemical fractionation 
which will be reported in a subsequent paper. 
CONCLUSIONS 
1.  In an effort to explain a certain lack of parallelism between the 
antibody content and the protective values of antipneumococcus  horse 
sera, experiments have been carried out in which determined propor- KENNETH GOODNER AND I~RANK L.  HORS~FALL, JR.  435 
tions of the specific antibody have been removed from sera and the 
protective values of the residuum determined. 
2.  These  experiments with  immunological fractionation  have  re- 
vealed that  the  specific antibodies of immune sera do  not possess 
uniform mouse protective potencies.  The inference is that there may 
be several different substances in immune sera, each dominantly spe- 
cific,  yet  exhibiting  marked  differences in  avidity  and  in  protec- 
tive value. 
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